TY - JOUR
T1 - Co-expression of MDR-associated markers, including P-170, MRP and LRP and gytoskeletal proteins, in three resistant variants of the human ovarian garcinoma cell line, OAW42
AU - Moran, E.
AU - Cleary, I.
AU - Larkin, A. M.
AU - Amhlaoibh, R. Nic
AU - Masterson, A.
AU - Scheper, R. J.
AU - Izquierdo, M. A.
AU - Center, M.
AU - O'Sullivan, F.
AU - Clynes, M.
PY - 1997/4
Y1 - 1997/4
N2 - Variants of the human ovarian carcinoma cell line, OAW42, exhibiting low-level intrinsic resistance (OAW42-SR) and drug-induced higher-level resistance (OAW42-A1 and OAW42-A), were studied along with a sensitive clonal population (OAW42-S) which was isolated from OAW42-SR. Expression of the MDR- associated protein P-170, the more recently discovered LRP (lung resistance- related protein) and MRP (multidrug resistance-associated protein), topoisomerase IIα and β, GSTπ and the cytoskeletal proteins, cytokeratin 8 and vimentin, were studied (using immunocytochemistry and Western blotting techniques) in conjunction with drug (doxorubicin) accumulation and subcellular distribution. Expression of mRNA for P-170, MRP, topoisomerase 11α and β and GSTπ was studied using RT-PCR (reverse transcriptase polymerase chain reaction). Results indicate differential co-expression of four MDR-associated parameters (P-170, MRP, LRP and reduced topoisomerase IIα and β) in the OAW42-SR and OAW42-A1 variants, whereas resistance in the OAW42-A variant appeared to be mainly P-170 mediated. Comparable amounts of MRP and greater amounts of LRP were detected in the OAW42-S cells compared to the OAW42-SR variant (which showed increased resistance compared to the OAW42-S cells), but all cell lines expressed similar low-level amounts of MRP mRNA (by RT-PGR). GSTTπ levels did not differ markedly between variants. Increased levels of the cytoskeletal proteins were observed with increasing levels of resistance. The relative resistance of the variants, OAW42-SR and OAW42-A1, compared with OAW42-S was seen to change during increased serial passaging of the cells. There was greater drug accumulation by the sensitive OAW42-S ceil line compared with that of the resistant variants, particularly the most highly resistant OAW42-A cells. Both verapamil and cyclosporin A effectively restored the accumulation defects seen in the resistant variants, cyclosporin A being the more effective of the two. Subcellular location of drug was predominantly in the nucleus with maximum levels seen in the sensitive OAW42-S variant and minimum levels in the most resistant OAW42-A clone.
AB - Variants of the human ovarian carcinoma cell line, OAW42, exhibiting low-level intrinsic resistance (OAW42-SR) and drug-induced higher-level resistance (OAW42-A1 and OAW42-A), were studied along with a sensitive clonal population (OAW42-S) which was isolated from OAW42-SR. Expression of the MDR- associated protein P-170, the more recently discovered LRP (lung resistance- related protein) and MRP (multidrug resistance-associated protein), topoisomerase IIα and β, GSTπ and the cytoskeletal proteins, cytokeratin 8 and vimentin, were studied (using immunocytochemistry and Western blotting techniques) in conjunction with drug (doxorubicin) accumulation and subcellular distribution. Expression of mRNA for P-170, MRP, topoisomerase 11α and β and GSTπ was studied using RT-PCR (reverse transcriptase polymerase chain reaction). Results indicate differential co-expression of four MDR-associated parameters (P-170, MRP, LRP and reduced topoisomerase IIα and β) in the OAW42-SR and OAW42-A1 variants, whereas resistance in the OAW42-A variant appeared to be mainly P-170 mediated. Comparable amounts of MRP and greater amounts of LRP were detected in the OAW42-S cells compared to the OAW42-SR variant (which showed increased resistance compared to the OAW42-S cells), but all cell lines expressed similar low-level amounts of MRP mRNA (by RT-PGR). GSTTπ levels did not differ markedly between variants. Increased levels of the cytoskeletal proteins were observed with increasing levels of resistance. The relative resistance of the variants, OAW42-SR and OAW42-A1, compared with OAW42-S was seen to change during increased serial passaging of the cells. There was greater drug accumulation by the sensitive OAW42-S ceil line compared with that of the resistant variants, particularly the most highly resistant OAW42-A cells. Both verapamil and cyclosporin A effectively restored the accumulation defects seen in the resistant variants, cyclosporin A being the more effective of the two. Subcellular location of drug was predominantly in the nucleus with maximum levels seen in the sensitive OAW42-S variant and minimum levels in the most resistant OAW42-A clone.
KW - GSTπ
KW - LRP
KW - MRP
KW - P-170
KW - cytokeratin
KW - doxorubicin
KW - topoisomerase IIα
KW - vimentin
UR - http://www.scopus.com/inward/record.url?scp=0030983260&partnerID=8YFLogxK
U2 - 10.1016/S0959-8049(96)00501-1
DO - 10.1016/S0959-8049(96)00501-1
M3 - Article
C2 - 9274450
AN - SCOPUS:0030983260
SN - 0959-8049
VL - 33
SP - 652
EP - 660
JO - European Journal of Cancer Part A
JF - European Journal of Cancer Part A
IS - 4
ER -